nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—POU2F2—Ectoderm Differentiation—TOX3—restless legs syndrome	0.786	0.786	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—TF—restless legs syndrome	0.2	0.2	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—POMC—restless legs syndrome	0.0123	0.0123	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—POMC—restless legs syndrome	0.0021	0.0021	CbGpPWpGaD
